Volume 29, 2022
Bioactive lipids and lipid droplets: green ressources for food and health / Lipides et gouttelettes lipidiques bioactifs : des ressources vertes pour l’alimentation et la santé
Article Number 1
Number of page(s) 7
Published online 04 January 2022
  • Aguirre TAS, Teijeiro-Osorio D, Rosa M, Coulter IS, Alonso MJ, Brayden DJ. 2016. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials. Adv Drug Deliv Rev 106: 223–241. [CrossRef] [PubMed] [Google Scholar]
  • Banerjee A, Qi J, Gogoi R, Wong J, Mitragotri S. 2016. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release: Off J Control Release Soc 238: 176–185. [CrossRef] [Google Scholar]
  • Beloqui A, Solinís MÁ, Rodríguez-Gascón A, Almeida AJ, Préat V. 2016. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomed: Nanotechnol Biol Med 12: 143–161. [CrossRef] [Google Scholar]
  • Chamieh J, Domènech Tarrat A, Doudou C, Jannin V, Demarne F, Cottet H. 2019. Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis. Int J Pharm 559: 228–234. [CrossRef] [PubMed] [Google Scholar]
  • Craik DJ, Fairlie DP, Liras S, Price D. 2013. The future of peptide-based drugs. Chem Biol Drug Des 81: 136–147. [CrossRef] [PubMed] [Google Scholar]
  • Dumont C, Bourgeois S, Fessi H, Jannin V. 2018. Lipid-based nanosuspensions for oral delivery of peptides, a critical review. Int J Pharm 541: 117–135. [CrossRef] [PubMed] [Google Scholar]
  • Dumont C, Bourgeois S, Fessi H, Dugas P-Y, Jannin V. 2019a. In-vitro evaluation of solid lipid nanoparticles: Ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract. Int J Pharm 565: 409–418. [CrossRef] [PubMed] [Google Scholar]
  • Dumont C, Jannin V, Miolane C, et al. 2019b. A proof-of-concept for developing oral lipidized peptide nanostructured lipid carrier formulations. J Drug Deliv Sci Technol 54: 101394. [CrossRef] [Google Scholar]
  • Dumont C, Beloqui A, Miolane C, et al. 2020. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells – But where is my peptide? Int J Pharm 586: 119581. [CrossRef] [PubMed] [Google Scholar]
  • Griesser J, Hetényi G, Kadas H, Demarne F, Jannin V, Bernkop-Schnürch A. 2018. Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating. Int J Pharm 538: 159–166. [CrossRef] [PubMed] [Google Scholar]
  • Griesser J, Hetényi G, Moser M, Demarne F, Jannin V, Bernkop-Schnürch A. 2017. Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm 520: 267–274. [CrossRef] [PubMed] [Google Scholar]
  • Hetényi G, Griesser J, Moser M, Demarne F, Jannin V, Bernkop-Schnürch A. 2017. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione. Int J Pharm 523: 357–365. [CrossRef] [PubMed] [Google Scholar]
  • Leonaviciute G, Bernkop-Schnürch A. 2015. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery. Exp Opin Drug Deliv 12: 1703–1716. [CrossRef] [PubMed] [Google Scholar]
  • Malhaire H, Gimel J-C, Roger E, Benoît J-P, Lagarce F. 2016. How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability? Adv Drug Deliv Rev 106: 320–336. [CrossRef] [PubMed] [Google Scholar]
  • Morishita M, Peppas NA. 2006. Is the oral route possible for peptide and protein drug delivery? Drug Discov Today 11: 905–910. [CrossRef] [PubMed] [Google Scholar]
  • Müller RH. 2011. 20 years of lipid nanoparticles (SLN & NLC): Present state of development & industrial applications. Curr Drug Discov Technol 8: 207–27. [CrossRef] [PubMed] [Google Scholar]
  • Richard J. 2017. Challenges in oral peptide delivery: Lessons learnt from the clinic and future prospects. Ther Deliv 8: 663–684. [CrossRef] [PubMed] [Google Scholar]
  • Ristroph KD, Prud’homme RK. 2019. Hydrophobic ion pairing: Encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv 1: 4207–4237. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.